Search
Free Newsletters
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
About
Editions
Español
Deutsch
Français
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
Home
Latest
Business News
Money & Markets
Tech & Innovation
A.I.
Lifestyle
Leadership
✉️ Emails
🎧 Podcasts
TSLA
-3.33%
$282.30
-$9.74
GOOGL
-1.57%
$157.64
-$2.52
MSFT
-0.92%
$390.43
-$3.62
AMZN
-2.87%
$182.02
-$5.38
WMT
+0.77%
$96.78
+$0.74
AAPL
-0.39%
$210.38
-$0.83
META
-2.36%
$541.37
-$13.07
DIS
-1.33%
$89.96
-$1.21
CMCSA
+0.03%
$33.95
+$0.01
CRM
-0.74%
$265.78
-$1.98
TSLA
-3.33%
$282.30
-$9.74
GOOGL
-1.57%
$157.64
-$2.52
MSFT
-0.92%
$390.43
-$3.62
AMZN
-2.87%
$182.02
-$5.38
WMT
+0.77%
$96.78
+$0.74
AAPL
-0.39%
$210.38
-$0.83
META
-2.36%
$541.37
-$13.07
DIS
-1.33%
$89.96
-$1.21
CMCSA
+0.03%
$33.95
+$0.01
CRM
-0.74%
$265.78
-$1.98
Markets
RECENT NEWS
Noom wants to be 'the Duolingo of health'
June 3, 2025
Weight Watchers goes bankrupt even as it tries to ride the Ozempic boom
May 7, 2025
Ozempic lures people to the doctor, Nestle's GLP-1 'shot,' an FDA Zepbound ruling: Pharma news roundup
December 20, 2024
What's ahead for weight loss drugs in 2025, according to Noom's CEO
December 16, 2024
Advertisement